Almost everyone is at risk of shingles because they are likely to have been exposed to chickenpox, even if they have no history of clinical chickenpox or chickenpox vaccination. Following chickenpox infection, the virus lies dormant in the nerves near the spine and may re-emerge many years later as shingles. Shingles most commonly affects older adults or people of any age with a weakened immune system. It can be given to patients who have previously had shingles. This vaccine contains a weakened form of the varicella-zoster virus, and as a live viral vaccine, is not suitable for some people with medical conditions or who are receiving treatments that affect their immune system.
|Published (Last):||7 September 2011|
|PDF File Size:||15.46 Mb|
|ePub File Size:||11.45 Mb|
|Price:||Free* [*Free Regsitration Required]|
This section contains information intended for health care professionals in the United States only and is not intended for the general public. Yes, I am. This site is intended only for residents of the United States, its territories, and Puerto Rico. Do not administer ZOSTAVAX to individuals who are immunodeficient or immunosuppressed due to disease or therapy, as serious or fatal disseminated vaccine strain varicella-zoster virus disease may occur. Causes of immunodeficiency or immunosuppression may include, but are not limited to, primary or acquired immunodeficiency states, AIDS or other clinical manifestations of infection with human immunodeficiency viruses, leukemia, lymphoma or other malignant neoplasms affecting the bone marrow or lymphatic system, and immunosuppressive therapy.
Consider administration of the two vaccines separated by at least 4 weeks. Serious vaccine-related adverse reactions that have occurred following vaccination with ZOSTAVAX include asthma exacerbation and polymyalgia rheumatica.
Deferral should be considered in acute illness for example, in the presence of fever or in patients with active untreated tuberculosis. The Patient Information also is available. Merck does not review or control the content at the site to which this link connects. Merck makes no representation with respect to the content of any non-Merck site.
Skip to content. Even healthy adults have an increased risk for zoster 1. Pharmacists play an important role 2. Learn about zoster vaccination in the pharmacy. J Gen Intern Med. Please specify information package VACC Transmission of vaccine virus may occur between vaccinees and susceptible contacts.
You are about to leave MerckVaccines. Cancel Continue.
About the Vaccine
A new shingles vaccine called Shingrix was licensed by the U. CDC recommends that healthy adults 50 years and older get two doses of Shingrix, 2 to 6 months apart. Shingrix provides strong protection against shingles and PHN. Shingrix is the preferred vaccine, over Zostavax. Zostavax is administered subcutaneously as a single dose in the deltoid region. The vaccine should not be injected intramuscularly.
- OTOMATIK KONTROL SISTEMLERI BENJAMIN KUO PDF
- KRAUTROCK SAMPLER PDF
- LEYMANN INVENTORY OF PSYCHOLOGICAL TERRORIZATION PDF
- ALICIZATION INVADING PDF
- ARMY TGC 119 NOTIFICATION PDF
- BUMBLAUSKAS SENOSIOS LIETUVOS ISTORIJA PDF
- HARRY OSERS GEOMETRIA DESCRIPTIVA PDF
- CIENCIA E ENGENHARIA DOS MATERIAIS CALLISTER PDF